ESSA Pharma Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BVF INC/IL | 05/15/2025 | 8.75 M | $13.82 M | 0.00% | 19.71% |
TANG CAPITAL MANAGEMENT LLC | 05/15/2025 | 4.30 M | $6.79 M | 0.00% | 9.69% |
MORGAN STANLEY | 05/15/2025 | 4.30 M | $6.79 M | 2.48% | 9.69% |
BML CAPITAL MANAGEMENT, LLC | 05/07/2025 | 4.22 M | $6.67 M | 0.00% | 9.51% |
SOLEUS CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 2.26 M | $3.57 M | 0.00% | 5.10% |
OPALEYE MANAGEMENT INC. | 05/15/2025 | 2.21 M | $3.49 M | 0.00% | 4.98% |
PFIZER INC | 05/13/2025 | 1.68 M | $2.65 B | 0.00% | 3.77% |
ALTIUM CAPITAL MANAGEMENT LP | 05/13/2025 | 1.05 M | $1.66 B | -26.44% | 2.37% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 698.27 K | $1.10 M | -14.04% | 1.57% |
ALDEBARAN CAPITAL, LLC | 05/13/2025 | 569.29 K | $899.49 K | 43.21% | 1.28% |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 279.12 K | $441.01 K | 32.16% | 0.63% |
TWO SIGMA ADVISERS, LP | 05/15/2025 | 276.10 K | $436.24 K | 234.26% | 0.62% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 235.40 K | $371.93 K | 43.02% | 0.53% |
DLD ASSET MANAGEMENT, LP | 05/14/2025 | 183.66 K | $290.18 K | 100.00% | 0.41% |
JPMORGAN CHASE & CO | 05/12/2025 | 164.88 K | $260.50 K | 785,019.05% | 0.37% |
DEUTERIUM CAPITAL MANAGEMENT, LLC | 05/08/2025 | 110.41 K | $174.45 K | 100.00% | 0.25% |
CITADEL ADVISORS LLC | 05/15/2025 | 82.12 K | $129.75 K | -48.36% | 0.19% |
MAGNUS FINANCIAL GROUP LLC | 04/11/2025 | 55.21 K | $87.23 K | 0.00% | 0.12% |
AMERICAN CENTURY COMPANIES INC | 05/13/2025 | 46.37 K | $73.27 K | 0.00% | 0.10% |
CITADEL ADVISORS LLC | 05/15/2025 | 42.30 K | $66.83 K | 75.52% | 0.10% |
LEPERCQ DE NEUFLIZE ASSET MANAGEMENT LLC | 05/13/2025 | 31.70 K | $50.09 K | 4.97% | 0.07% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 26.86 K | $42.44 K | 0.00% | 0.06% |
SHAY CAPITAL LLC | 05/15/2025 | 24.63 K | $38.92 K | 100.00% | 0.06% |
SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2025 | 22.84 K | $36.09 K | -53.23% | 0.05% |
XTX TOPCO LTD | 05/08/2025 | 22.83 K | $36.07 K | -39.16% | 0.05% |
GROUP ONE TRADING, L.P. | 05/14/2025 | 21.12 K | $33.37 K | -41.90% | 0.05% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 05/15/2025 | 14.12 K | $22.30 K | -46.30% | 0.03% |
BLACKROCK, INC. | 05/02/2025 | 7.07 K | $11.18 K | 0.00% | 0.02% |
ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 6.00 K | $9.48 K | 0.00% | 0.01% |
FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 05/15/2025 | 4.05 K | $6.40 K | 0.00% | 0.01% |
TRUVESTMENTS CAPITAL LLC | 05/14/2025 | 3.69 K | $5.83 K | -6.42% | 0.01% |
CIBC PRIVATE WEALTH GROUP, LLC | 05/14/2025 | 2.50 K | $3.68 K | 0.00% | 0.01% |
TD WATERHOUSE CANADA INC. | 05/09/2025 | 900 | $1.40 K | 0.00% | 0.00% |
ROYAL BANK OF CANADA | 05/15/2025 | 817 | $1.00 K | -11.00% | 0.00% |
LAUREL WEALTH ADVISORS LLC | 04/15/2025 | 600 | $948 | 0.00% | 0.00% |
BARCLAYS PLC | 05/15/2025 | 355 | $1.00 K | 0.00% | 0.00% |
CITADEL ADVISORS LLC | 05/15/2025 | 200 | $316 | -98.68% | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 0 | $0 | -100.00% | 0.00% |
MARSHALL WACE, LLP | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
PRELUDE CAPITAL MANAGEMENT, LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
TWO SIGMA SECURITIES, LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
GTS SECURITIES LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
RTW INVESTMENTS, LP | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
JANE STREET GROUP, LLC | 05/19/2025 | 0 | $0 | -100.00% | 0.00% |
SQUAREPOINT OPS LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
VAZIRANI ASSET MANAGEMENT LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
FNY INVESTMENT ADVISERS, LLC | 04/17/2025 | 0 | $0 | -100.00% | 0.00% |
49 WEALTH MANAGEMENT, LLC | 04/30/2025 | 0 | $0 | -100.00% | 0.00% |
ESSA Pharma Inc. institutional Ownership - FAQ's
During the previous two years, 53 institutional investors and hedge funds held shares of ESSA Pharma Inc.. The most heavily invested institutionals were:
BVF INC/IL: 8.75 M
TANG CAPITAL MANAGEMENT LLC: 4.3 M
MORGAN STANLEY: 4.3 M
BML Capital Management, LLC: 4.22 M
Soleus Capital Management, L.P.: 2.26 M
Opaleye Management Inc.: 2.21 M
71.37% of ESSA Pharma Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 33.50 M shares in the last 24 months. This purchase volume represents approximately $56.61 M in transactions.